People · Operator

Marc Balkin

Named in public records as an officer, director or promoter · active 2012–2024 · Other Technology, Biotechnology

2
Companies
4
Filings
$6.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
KnowledgeTree, Inc.Other TechnologySeed$4.7M$45.7M2012
Psyence Biomedical Ltd.BiotechnologySeed$2.0M$7.4M2024
Operator network

Marc Balkin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

William Dunbar · 4 companies · 1 sharedWilliam DunbarEdward McCarthy · 3 companies · 1 sharedEdward McCarthyWill Dunbar · 3 companies · 1 sharedWill DunbarAlex Osadzinski · 2 companies · 1 sharedAlex OsadzinskiDaniel Chalef · 2 companies · 1 sharedDaniel ChalefED MCCARTHY · 2 companies · 1 sharedED MCCARTHYJOHN THORNE · 2 companies · 1 sharedJOHN THORNEPeter Mollins · 1 companies · 1 sharedPeter MollinsJody Aufrichtig · 2 companies · 1 sharedJody AufrichtigBull Christopher · 1 companies · 1 sharedBull ChristopherDr. Seth Feuerstein · 1 companies · 1 sharedDr. Seth Feuerste…Neil Maresky · 1 companies · 1 sharedNeil MareskyWarwick Corden-Lloyd · 1 companies · 1 sharedWarwick Corden-Ll…KnowledgeTree, Inc. · $4.7M raisedKnowledgeTree, Inc.Psyence Biomedical Ltd. · $2.0M raisedPsyence Biomedical Lt…Marc BalkinMB
Marc Balkin Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Marc Balkin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
William Dunbar14
Will Dunbar13
Edward McCarthy13
Alex Osadzinski12
Daniel Chalef12
ED MCCARTHY12
JOHN THORNE12
Jody Aufrichtig12
Peter Mollins11
Neil Maresky11
Dr. Seth Feuerstein11
Warwick Corden-Lloyd11
Bull Christopher11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.